{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:34:20Z","timestamp":1793860460026,"version":"4.6.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL131768"],"award-info":[{"award-number":["R01HL131768"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"Science for Life Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.xcrm.2022.100657","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T18:03:48Z","timestamp":1654797828000},"page":"100657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["The immune cell atlas of human neuroblastoma"],"prefix":"10.1016","volume":"3","author":[{"given":"Bronte Manouk","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thale Kristin","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Valind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gisselsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad Shirazi","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Hagerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Kharchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Kogner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Inge","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninib","family":"Baryawno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100657_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2019.00009","article-title":"Neuroblastoma\u2014a neural crest derived embryonal malignancy","volume":"12","author":"Johnsen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.xcrm.2022.100657_bib2","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100657_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib4","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2022.100657_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1019981","article-title":"Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma","volume":"4","author":"Mina","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2022.100657_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2020.11.014","article-title":"The immune landscape of neuroblastoma: challenges and opportunities for novel therapeutic strategies in pediatric oncology","volume":"144","author":"Wienke","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2022.100657_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216373","article-title":"Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function","volume":"14","author":"Oll\u00e9 Hurtado","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100657_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s002620050267","article-title":"Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: Neuroblastoma","volume":"42","author":"Facchetti","year":"1996","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2022.100657_bib9","first-page":"362","article-title":"T-cell receptor repertoire in neuroblastoma patients","volume":"56","author":"Valteau","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100657_bib10","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1158\/1078-0432.CCR-18-0599","article-title":"Clinically relevant cytotoxic immune cell signatures and clonal expansion of T-cell receptors in high-risk MYCN-not-amplified human neuroblastoma","volume":"24","author":"Wei","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100657_bib11","doi-asserted-by":"crossref","first-page":"e23618","DOI":"10.4161\/onci.23618","article-title":"The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes","volume":"2","author":"Carlson","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2022.100657_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.aas9673","article-title":"Location, location, location: tissue resident memory T\u00a0cells in mice and humans","volume":"4","author":"Szabo","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00383-017-4189-x","article-title":"Invariant natural killer T infiltration in neuroblastoma with favorable outcome","volume":"34","author":"Hishiki","year":"2018","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.xcrm.2022.100657_bib14","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1038\/s41467-020-19781-y","article-title":"Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma","volume":"11","author":"Melaiu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100657_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.01473","article-title":"MYCN amplification is associated with repressed cellular immunity in neuroblastoma: an in\u00a0silico immunological analysis of TARGET database","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/path.4769","article-title":"Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development","volume":"240","author":"Hashimoto","year":"2016","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.xcrm.2022.100657_bib17","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2011.40.9169","article-title":"Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma","volume":"30","author":"Asgharzadeh","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100657_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cellimm.2018.02.008","article-title":"Myeloid cell heterogeneity in cancer: not a single cell alike","volume":"330","author":"Kiss","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib20","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/1078-0432.CCR-15-1912","article-title":"Targeting suppressive myeloid cells potentiates checkpoint inhibitors to control spontaneous neuroblastoma","volume":"22","author":"Mao","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100657_bib21","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3390\/cancers13071743","article-title":"Combined effects of myeloid cells in the neuroblastoma tumor microenvironment","volume":"13","author":"Frosch","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2022.100657_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/carcin\/bgt009","article-title":"Low-dose aspirin delays an inflammatory tumor progression in\u00a0vivo in a transgenic mouse model of neuroblastoma","volume":"34","author":"Carlson","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.xcrm.2022.100657_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MPH.0000000000001369","article-title":"Advances in anti-GD2 immunotherapy for treatment of high-risk neuroblastoma","volume":"41","author":"Voeller","year":"2019","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2022.100657_bib24","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1158\/1078-0432.CCR-20-3909","article-title":"Long-term follow-up of a phase III study of ch14.18 (dinutuximab)\u00a0+ cytokine immunotherapy in children with high-risk neuroblastoma: COG study ANBL0032","volume":"27","author":"Yu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100657_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-021-00818-x","article-title":"Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin","volume":"53","author":"Kameneva","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100657_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abd3311","article-title":"Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell","volume":"7","author":"Kildisiute","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2022.100657_bib27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ccell.2020.08.014","article-title":"Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma","volume":"38","author":"Dong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib28","article-title":"Malignant Schwann cell precursors mediate intratumoral plasticity in human neuroblastoma","author":"Olsen","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100657_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022350118","article-title":"Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype","volume":"118","author":"Hanemaaijer","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.xcrm.2022.100657_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-24870-7","article-title":"Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors","volume":"12","author":"Bedoya-Reina","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100657_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41588-021-00806-1","article-title":"Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma","volume":"53","author":"Jansky","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100657_bib32","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41592-019-0466-z","article-title":"Joint analysis of heterogeneous single-cell RNA-seq dataset collections","volume":"16","author":"Barkas","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2022.100657_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00173","article-title":"Allograft inflammatory factor-1 governs hematopoietic stem cell differentiation into CDC1 and monocyte-derived dendritic cells through IRF8 and RelB in\u00a0vitro","volume":"10","author":"Elizondo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100657_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-017-1503-x","article-title":"BANK1 alters B cell responses and influences the interactions between B cells and induced T regulatory cells in mice with collagen-induced arthritis","volume":"20","author":"Yang","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.xcrm.2022.100657_bib37","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar3908","article-title":"B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies","volume":"15","author":"Leandro","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.xcrm.2022.100657_bib38","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T\u00a0cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100657_bib39","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1038\/s41467-019-11947-7","article-title":"Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100657_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12967-018-1578-4","article-title":"PBMC fixation and processing for Chromium single-cell RNA sequencing","volume":"16","author":"Chen","year":"2018","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.xcrm.2022.100657_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2022.100657_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib43","doi-asserted-by":"crossref","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100657_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo Antunes","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2022.100657_bib45","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1038\/s41467-020-18546-x","article-title":"A gene expression signature of TREM2hi macrophages and \u03b3\u03b4 T\u00a0cells predicts immunotherapy response","volume":"11","author":"Xiong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100657_bib46","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2022.100657_bib47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S1679-45082015RB3438","article-title":"Chemokines and immunity","volume":"13","author":"Palomino","year":"2015","journal-title":"Einstein"},{"key":"10.1016\/j.xcrm.2022.100657_bib48","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ccell.2021.03.007","article-title":"Single-cell sequencing links multiregional immune landscapes and tissue-resident T\u00a0cells in ccRCC to tumor topology and therapy efficacy","volume":"39","author":"Krishna","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib49","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.1502163","article-title":"CD83 modulates B cell activation and germinal center responses","volume":"196","author":"Krzyzak","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib50","doi-asserted-by":"crossref","first-page":"eabe6291","DOI":"10.1126\/sciimmunol.abe6291","article-title":"Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics","volume":"6","author":"King","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100657_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-020-00446-2","article-title":"Transcriptional regulation of memory B cell differentiation","volume":"21","author":"Laidlaw","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imm.13176","article-title":"V(D)V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation","volume":"160","author":"Chi","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2022.100657_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200483","article-title":"Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome","volume":"217","author":"Holmes","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2022.100657_bib55","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/leu.2016.226","article-title":"Human memory B cells","volume":"30","author":"Seifert","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2022.100657_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-230X(03)90004-2","article-title":"Natural killer cells and cancer","volume":"90","author":"Wu","year":"2003","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100657_bib57","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","article-title":"Influence of the tumor microenvironment on NK cell function in solid tumors","volume":"10","author":"Melaiu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib58","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue determinants of human NK cell development, function, and residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ni.3368","article-title":"The heterogeneity of human CD127+ innate lymphoid cells revealed by single-cell RNA sequencing","volume":"17","author":"Bj\u00f6rklund","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib60","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T\u00a0cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100657_bib61","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T\u00a0cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T\u00a0cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib63","article-title":"T cell dysfunction and exhaustion in cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2022.100657_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181868","article-title":"ROR\u03b3t and ROR\u03b1 signature genes in human Th17 cells","volume":"12","author":"Castro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100657_bib65","doi-asserted-by":"crossref","first-page":"108343","DOI":"10.1016\/j.clim.2020.108343","article-title":"The increased IL-17-producing \u03b3\u03b4T cells promote tumor cell proliferation and migration in neuroblastoma","volume":"211","author":"Zhang","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib66","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/cmi.2015.10","article-title":"FOXP3+ regulatory T\u00a0cells and their functional regulation","volume":"12","author":"Li","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib67","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib68","doi-asserted-by":"crossref","first-page":"e2836","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2022.100657_bib69","doi-asserted-by":"crossref","first-page":"e8017","DOI":"10.7717\/peerj.8017","article-title":"Cellular components in tumor microenvironment of neuroblastoma and the prognostic value","volume":"7","author":"Zhong","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.xcrm.2022.100657_bib70","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1158\/1078-0432.CCR-16-2601","article-title":"PD-L1 is a therapeutic target of the bromodomain inhibitor JQ1 and, combined with HLA class I, a promising prognostic biomarker in neuroblastoma","volume":"23","author":"Melaiu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100657_bib71","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell\u2013cell communication from combined expression of multi-subunit ligand\u2013receptor complexes","volume":"15","author":"Efremova","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2022.100657_bib72","unstructured":"Groningen, T. V., Akogul, N., Westerhout, E. M., Chan, A. & Hasselt, N. E. A NOTCH feed-forward loop drives reprogramming from adrenergic- to mesenchymal state in neuroblastoma.Nat. Commun. 10,.1530"},{"key":"10.1016\/j.xcrm.2022.100657_bib73","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semcancer.2004.04.016","article-title":"Notch signaling in neuroblastoma","volume":"14","author":"P\u00e5hlman","year":"2004","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2022.100657_bib74","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.3390\/cancers13215293","article-title":"NTRK1\/TrkA signaling in neuroblastoma cells induces nuclear reorganization and intra-nuclear aggregation of lamin A\/C","author":"Funke","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2022.100657_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100657_bib76","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/cancers13092096","article-title":"Immune monitoring during therapy reveals activitory and regulatory immune responses in high-risk neuroblastoma","volume":"13","author":"Szanto","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2022.100657_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib78","first-page":"1","article-title":"\u201cRe-educating\u201d tumor associated macrophages as a novel immunotherapy strategy for neuroblastoma","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2011.00098","article-title":"Chronic inflammation in cancer development","volume":"2","author":"Multhoff","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib80","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100657_bib81","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Author Correction: tertiary lymphoid structures improve immunotherapy and survival in melanoma.","volume":"580","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100657_bib82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-019-0779-5","article-title":"Immune checkpoint inhibitors of PD-L1 as cancer therapeutics","volume":"12","author":"Akinleye","year":"2019","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2022.100657_bib83","doi-asserted-by":"crossref","first-page":"e002591","DOI":"10.1136\/jitc-2021-002591","article-title":"Mechanisms of regulatory T\u00a0cell infiltration in tumors: implications for innovative immune precision therapies","volume":"9","author":"Nishikawa","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2022.100657_bib84","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.scr.2015.08.008","article-title":"A distinct gene expression signature characterizes human neuroblastoma cancer stem cells","volume":"15","author":"Ross","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.xcrm.2022.100657_bib85","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","article-title":"Inhibitory CD161 receptor identified in glioma-infiltrating T\u00a0cells by single-cell analysis","volume":"184","author":"Mathewson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-020-00356-8","article-title":"TREM2 marks tumor-associated macrophages","volume":"5","author":"Nakamura","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2022.100657_bib87","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100657_bib88","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","article-title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","volume":"119","author":"Ndhlovu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2022.100657_bib89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2020.00167","article-title":"NK cell-based immune checkpoint inhibition","volume":"11","author":"Khan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100657_bib90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100657_bib91","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-021-04061-6","article-title":"Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs","author":"Yarmarkovich","year":"2021","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:50:44Z","timestamp":1762987844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2666379122001896"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100657","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune cell atlas of human neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100657"}}